Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: A nested case-control study within a European prospective cohort study

Gut

Volumn 58, Issue 12, 2009, Pages 1606-1611

  Hart, A ^a   Tjonneland, A ^b   Olsen, A ^b   Overvad, K ^c   Bergmann, M M ^d   Boeing, H ^d   Nagel, G ^e,f   Linseisen, J ^e   Hallmans, G ^g   Danielsson, A ^g   Palmqvist, R ^g   Sjodin, H ^h   Hagglund G ^g   Berglund, G ⁱ   Lindgren, S ⁱ   Grip, O ⁱ   Palli, D ^j   Masala, G ^j   Day, N E ^k   Luben, R ^k   Welch, A ^k   Khaw, K T ^l   Bingham, S ^m   Riboli, E ⁿ   Kennedy, H ^o   more..

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^e Division of Clinical Epidemiology   (Germany)

^f UNIVERSITY OF ULM   (Germany)

^g UMEÅ UNIVERSITY   (Sweden)

^h UMEÅ UNIVERSITY HOSPITAL   (Sweden)

ⁱ LUND UNIVERSITY HOSPITAL   (Sweden)

^j ISPO Cancer Prevention and Research Institute   (Italy)

^k UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^l ADDENBROOKE S HOSPITAL   (United Kingdom)

^m UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁿ IMPERIAL COLLEGE LONDON   (United Kingdom)

^o NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LINOLEIC ACID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; ULCERATIVE COLITIS; ULCEROGENESIS;

ADULT; AGED; COLITIS, ULCERATIVE; DIET; DIETARY FATS, UNSATURATED; EPIDEMIOLOGIC METHODS; EUROPE; FEMALE; FOOD HABITS; HUMANS; LINOLEIC ACID; MALE; MIDDLE AGED;

EID: 72549092109     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.169078     Document Type: Article

References (35)

1. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-535 (Pubitemid 32234798)
2. Nishida T, Miwa H, Shigematsu A, et al. Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis. Gut 1987;28:1002-1007 (Pubitemid 17119267)
3. Rampton D, Collins C. Review article: thromboxanes in inflammatory bowel disease - pathogenic and therapeutic implications. Aliment Pharmacol Ther 1993;7:357-367 (Pubitemid 23267012)
4. Sharon P, Ligumsky M, Rachilewitz D, et al. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology 1978;75:638-640
5. Sharon P, Stenson W. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 1984;86:453-460 (Pubitemid 14154655)
6. Geerling BJ, Dagnelie PC, Badart-Smook A, et al. Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol 2000;95:1008-1013 (Pubitemid 30196738)
7. Hart A, Luben R, Olsen A, et al. Diet in the aetiology of ulcerative colitis - A European prospective cohort study. Digestion 2008;77:57-64. (Pubitemid 351552979)
8. Reif S, Klein I, Lubin F, et al. Pre-illness dietary factors in inflammatory bowel disease. Gut 1997;40:754-760 (Pubitemid 27305468)
9. Riboli E. Nutrition and cancer: background and rationale of the European Prospective Investigation into Cancer and Nutrition. Ann Oncol 1992;3:783-791 (Pubitemid 23002470)
10. Kaaks R, Slimani N, Riboli E. Pilot phase studies on the accuracy of dietary intake measurements in the EPIC project: overall evaluation of results. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997;26:S26-36.
11. Margetts BM, Pietinen P. European Prospective Investigation into Cancer and Nutrition: Validity studies on dietary assessment methods. Int J Epidemiol 1997;26:S1-5. (Pubitemid 27129684)
12. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989;34:1841-1854 (Pubitemid 20018648)
13. Logan R, Kay CR. Oral contraception, smoking and inflammatory bowel disease - findings in the Royal College of General Practitioners Oral Contraception Study. Int J Epidemiol 1989;18:105-107 (Pubitemid 19128640)
14. Goldman DW, Pickett WC, Goetzl EJ. Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid. Biochem Biophys Res Comm 1983;117:282-288
15. Heller A, Koch T, Schmeck J, et al. Lipid mediators in inflammatory disorders. Drugs 1998;55:487-496
16. Lee TH, Mencia-Huerta JM, Shih C, et al. Characterization and biological properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product. J Biol Chem 1984;259:2383-2389 (Pubitemid 14190356)
17. Kitchen E, Boot JR, Dawson W. Chemotactic activity of thromboxane B2, prostaglandins and their metabolites for polymorponuclear leucocytes. Prostaglandins 1978;16:239-244 (Pubitemid 9026984)
18. Goldman G, Welbourn R, Valeri C, et al. Thromboxane A2 induces leukotriene B4 synthesis that in turn mediates neutrophil diapedesis via CD18 activation. Microvasc Res 1991;41:367-375
19. Kelly JP, Johnson MC, Parker CW. Effect of inhibitors of arachidonic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygenase pathway. J Immunol 1979;122:1563-1571
20. 14C]-arachidonic acid by human colonic mucosa. Gut 1983;24:1176-1182
21. Diaz O, Berquand A, Dubois M, et al. The mechanism of docosahexaenoic acid-induced phospholipase D activation in human lymphocytes involves exclusion of the enzyme from lipid rafts. J Biol Chem 2002;277:368-378 (Pubitemid 35190910)
22. May C, Southworth A, Calder PC. Inhibition of lymphocyte protein kinase C by unsaturated fatty acids. Biochem Biophys Res Commun 1993;195:823-828 (Pubitemid 23280490)
23. Speizer L, Watson M, Brunton L. Differential effects of omega-3 fish oils on protein kinase activities in vitro. Am J Physiol 1991;261:E109-14.
24. Robinson D, Urakaze M, Huang R, et al. Dietary marine lipids suppress continuous expression of interleukin-1 beta gene transcription. Lipids 1996;31:S23-S31. (Pubitemid 126673781)
25. Sakamoto N, Kono S, Wakai K, et al. Dietary risk factors for inflammatory bowel disease: a multi-centre case-control study in Japan. Inflammatory bowel diseases 2004;11:154-163 (Pubitemid 40711220)
26. Esteve-Comas M, Nunez M, Fernandez-Banares F, et al. Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease. Gut 1993;34:1370-1373 (Pubitemid 23293621)
27. Kawakami Y, Okada H, Murakami Y, et al. Dietary intake, neutrophil fatty acid profile, serum antioxidant vitamins and oxygen radical absorbance capacity in patients with ulcerative colitis. J Nutr Sci Vitaminol 2007;53:153-159 (Pubitemid 46933025)
28. Bingham SA, Gill C, Welch A, et al. Validation of dietary assessment methods in the UK arm of EPIC using weighed records and 24 hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol 1997;26(Suppl 1):S137-51. (Pubitemid 27129698)
29. Shivananda S, Lennard-Jones JE, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut 1996;39:690-697 (Pubitemid 26426470)
30. Lennard-Jones JE, Shivananda S. Clinical uniformity of inflammatory bowel disease at presentation and during the first year of disease in the north and south of Europe. EC-IBD Study group. Eur J Gastroenterol Hepatol 1997;9:353-359 (Pubitemid 27187332)
31. Henderson L, Gregory J, Irving K, et al. The National Diet and Nutrition Survey: adults aged 19-64 years. Office for National Statistics, Food Standards Agency 2003;2:67-76.
32. Gassull M, Fernandez-Banares F, Cabre E, et al. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut 2002;51:164-168 (Pubitemid 34791440)
33. Esteve-Comas M, Ramirez M, Fernandez-Banares F, et al. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease. Gut 1992;33:1365-1369
34. Geerling BJ, Houwelingen MD, Badart-Smook A, et al. Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn's disease, compared with controls. Am J Gastroenterol 1999;94:410-417 (Pubitemid 29084661)
35. Siguel E, Lerman R. Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders. Metabolism 1996;45:12-23. (Pubitemid 26104262)